Published in Int J Gynecol Pathol on July 01, 2007
Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation. Oncol Lett (2015) 0.81
Endocrine Disrupting Chemicals and Endometrial Cancer: An Overview of Recent Laboratory Evidence and Epidemiological Studies. Int J Environ Res Public Health (2017) 0.75
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92
A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol (2008) 5.26
Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med (2015) 4.94
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. J Clin Oncol (2011) 2.62
Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol (2002) 2.23
A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat (2003) 1.98
Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol (2006) 1.71
Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks. Int J Radiat Oncol Biol Phys (2005) 1.69
Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol (2007) 1.56
Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol (2006) 1.54
Development of a patient decision aid for choice of surgical treatment for breast cancer. Health Expect (1998) 1.48
Evaluation of two management strategies for preoperative grade 1 endometrial cancer. Obstet Gynecol (2009) 1.48
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses. Cancer (2007) 1.45
Sentinel lymph node in vulvar cancer. Cancer (2007) 1.44
Ontario radiation oncology residents' needs in the first postgraduate year-residents' perspective survey. Int J Radiat Oncol Biol Phys (2007) 1.43
Immunohistochemical characterization of primary and recurrent adult granulosa cell tumors. Int J Gynecol Pathol (2012) 1.39
Sentinel lymph nodes. Cancer (2003) 1.38
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer (2011) 1.33
Adenocarcinoma: a unique cervical cancer. Gynecol Oncol (2009) 1.30
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database Syst Rev (2009) 1.26
Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys (2005) 1.14
A novel, automated technology for multiplex biomarker imaging and application to breast cancer. Histopathology (2013) 1.12
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat (2015) 1.12
Fertility-sparing options for early stage cervical cancer. Gynecol Oncol (2010) 1.11
Invasive cervical cancer: a failure of screening. Eur J Public Health (2007) 1.10
Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. Gynecol Oncol (2003) 1.08
Underestimating underrecognition. Am J Clin Pathol (2013) 1.06
Intratumoral heterogeneity of HER2/neu in breast cancer--a rare event. Breast J (2007) 1.06
Metastatic renal cell carcinoma to the ovary: a case report and discussion of differential diagnoses. Arch Pathol Lab Med (2003) 1.05
Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol (2004) 1.02
CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg (2011) 1.01
Pathological splenic rupture: a rare complication of chronic myelomonocytic leukemia. Am J Hematol (2007) 1.01
Management of early and locally advanced cervical cancer. Semin Oncol (2009) 1.00
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys (2009) 1.00
A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184. Gynecol Oncol (2009) 1.00
Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol (2013) 0.99
Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol (2007) 0.99
Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix. Int J Gynecol Cancer (2010) 0.99
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity. Int J Radiat Oncol Biol Phys (2011) 0.99
Blue nevi of the Müllerian tract: case series and review of the literature. J Low Genit Tract Dis (2007) 0.98
Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol (2003) 0.98
From melanocyte to metastatic malignant melanoma. Dermatol Res Pract (2010) 0.97
Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Breast Cancer Res Treat (2004) 0.96
D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. Mod Pathol (2010) 0.95
CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma. Appl Immunohistochem Mol Morphol (2009) 0.94
Immunophenotyping of serous carcinoma of the female genital tract. Mod Pathol (2008) 0.92
Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma. Cancer (2003) 0.92
Improved lymph node retrieval in Whipple specimens as a result of implementation of a new uncinate margin protocol. HPB (Oxford) (2007) 0.91
The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation. Int J Radiat Oncol Biol Phys (2006) 0.91
Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol (2008) 0.91
Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology. Gynecol Oncol (2011) 0.90
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Res Treat (2013) 0.90
Cancer-associated nummular loss of RPE: expanding the clinical spectrum of bilateral diffuse uveal melanocytic proliferation. Ophthalmic Surg Lasers Imaging (2011) 0.90
Role of sentinel lymph node biopsy in cervical cancer: pro. Int J Gynecol Cancer (2010) 0.89
Palliative radiotherapy for cervical carcinoma, a systematic review. Radiother Oncol (2011) 0.89
Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma. Am J Clin Pathol (2008) 0.88
Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases. Diagn Pathol (2007) 0.88
Teaching cervical cancer surgery in low- or middle-resource countries. Int J Gynecol Cancer (2010) 0.87
High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells. Genes Chromosomes Cancer (2008) 0.87
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer. Int J Gynecol Cancer (2011) 0.87
Multimodal CME for surgeons and pathologists improves colon cancer staging. J Cancer Educ (2003) 0.87
Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma. Am J Clin Pathol (2011) 0.86
Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance. Am J Surg Pathol (2015) 0.86
'Atypical' and 'suspicious' diagnoses in breast aspiration cytology. Cancer (2004) 0.86
Venous thromboembolism in cervical cancer. Lancet Oncol (2008) 0.86
Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Cancer Genet Cytogenet (2004) 0.86
Effectiveness of educational intervention on the congruence of prostate and rectal contouring as compared with a gold standard in three-dimensional radiotherapy for prostate. Int J Radiat Oncol Biol Phys (2009) 0.86
Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol (2013) 0.86
Fine-needle aspiration biopsy of breast adenomyoepithelioma: a potential false positive pitfall and presence of intranuclear cytoplasmic inclusions. Diagn Cytopathol (2011) 0.86
Cancer of the cervix uteri. Int J Gynaecol Obstet (2012) 0.85
Systematic review of adjuvant care for women with Stage I ovarian carcinoma. Cancer (2004) 0.85
Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet. J Reprod Med (2004) 0.85
Multiple factors influence compliance with colorectal cancer staging recommendations: an exploratory study. BMC Health Serv Res (2008) 0.83
Her2 expression in prostatic cancer: a comparison with mammary carcinoma. J Urol (2002) 0.83
Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ. Histopathology (2014) 0.83
Endocervical adenocarcinoma in situ, serous type. Int J Gynecol Pathol (2009) 0.83
Integrating radiation into the management of vulvar cancer. Semin Radiat Oncol (2006) 0.82
Insulin receptor substrate 1 (IRS-1) plays a unique role in normal epidermal physiology. J Cell Physiol (2007) 0.82
Intraoperative consultation in gynecologic pathology: a 6-year audit at a tertiary care medical center. Int J Gynecol Cancer (2009) 0.81
Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings. Oncol Rep (2007) 0.81
Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. Arch Pathol Lab Med (2013) 0.81
Erythropoiesis stimulating agents, thrombosis and cancer. Radiother Oncol (2010) 0.81